Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05212922
Title A Study to Evaluate YH001 in Combination With Toripalimab in Subjects With Advanced NSCLC and HCC (YH001)
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Eucure (Beijing) Biopharma Co., Ltd

hepatocellular carcinoma

lung non-small cell carcinoma


Toripalimab + YH001

Age Groups: adult | senior
Covered Countries AUT

Additional content available in CKB BOOST